Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PCRX stock: Pacira Pharmaceuticals Inc

Current Rating
Hold/Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$45.15
Market Cap
1.93B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
8.3
P/S
6.58
Dividend %
-
P/CF
-
P/FCF
210.2
Op. Cash Flow
33.5K
FCF
0.2
Op. Margin
-11.60%
Net Margin
-13.70%
ROE
-17.10%
ROI
-9.80%
ROA
-9.70%
EPS Growth
-
Current Ratio
5.4
Debt/Equity
49.60%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Lannett Company, Inc. (LCI) $20.05 - - 965.1M Strong Buy
Navidea Biopharmaceuticals Inc (NAVB) $0.45 - - 79.2M Strong Buy
Nephros, Inc. (NEPH) $0.30 - - 16.2M Strong Buy
Aoxing Pharmaceutical Company (AXN) $0.36 - - 29.3M Strong Buy
Pen Inc (PENC) $1.88 - - 4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More